156 related articles for article (PubMed ID: 34049534)
1. Pyrvinium pamoate can overcome artemisinin's resistance in anaplastic thyroid cancer.
Li Y
BMC Complement Med Ther; 2021 May; 21(1):156. PubMed ID: 34049534
[TBL] [Abstract][Full Text] [Related]
2. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
Zhang C; Zhang Z; Zhang S; Wang W; Hu P
Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of PDH can Reduce Anaplastic Thyroid Cancer Cells' Sensitivity to Artemisinin.
Li Y
Anticancer Agents Med Chem; 2022; 22(9):1753-1760. PubMed ID: 34515013
[TBL] [Abstract][Full Text] [Related]
4. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
Cui L; Zhao J; Liu J
Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt/β-catenin pathway.
Zheng L; Liu Y; Pan J
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):890-898. PubMed ID: 28981601
[TBL] [Abstract][Full Text] [Related]
6. Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment.
Barbarino M; Cesari D; Intruglio R; Indovina P; Namagerdi A; Bertolino FM; Bottaro M; Rahmani D; Bellan C; Giordano A
J Cell Physiol; 2018 Sep; 233(9):7391-7401. PubMed ID: 29659015
[TBL] [Abstract][Full Text] [Related]
7. The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer.
Xu W; Lacerda L; Debeb BG; Atkinson RL; Solley TN; Li L; Orton D; McMurray JS; Hang BI; Lee E; Klopp AH; Ueno NT; Reuben JM; Krishnamurthy S; Woodward WA
PLoS One; 2013; 8(8):e71508. PubMed ID: 24013655
[TBL] [Abstract][Full Text] [Related]
8. Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance.
Khan HY; Ge J; Nagasaka M; Aboukameel A; Mpilla G; Muqbil I; Szlaczky M; Chaker M; Baloglu E; Landesman Y; Mohammad RM; Azmi AS; Sukari A
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905765
[TBL] [Abstract][Full Text] [Related]
9. The novel role of pyrvinium in cancer therapy.
Momtazi-Borojeni AA; Abdollahi E; Ghasemi F; Caraglia M; Sahebkar A
J Cell Physiol; 2018 Apr; 233(4):2871-2881. PubMed ID: 28500633
[TBL] [Abstract][Full Text] [Related]
10. Pyrvinium pamoate inhibits proliferation and invasion of human endometriotic stromal cells.
Karamian A; Nazarian H; Ziai SA; Zarnani AH; Salehpour S; Paktinat S; Novin MG
Hum Exp Toxicol; 2020 May; 39(5):662-672. PubMed ID: 31880170
[TBL] [Abstract][Full Text] [Related]
11. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
[TBL] [Abstract][Full Text] [Related]
12. Pyrvinium targets the unfolded protein response to hypoglycemia and its anti-tumor activity is enhanced by combination therapy.
Yu DH; Macdonald J; Liu G; Lee AS; Ly M; Davis T; Ke N; Zhou D; Wong-Staal F; Li QX
PLoS One; 2008; 3(12):e3951. PubMed ID: 19079611
[TBL] [Abstract][Full Text] [Related]
13. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol Suppresses the Growth and Enhances Retinoic Acid Sensitivity of Anaplastic Thyroid Cancer Cells.
Li YT; Tian XT; Wu ML; Zheng X; Kong QY; Cheng XX; Zhu GW; Liu J; Li H
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29596381
[TBL] [Abstract][Full Text] [Related]
15. Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: Insight on hedgehog/Gli and Wnt/β-catenin signaling crosstalk.
El-Derany MO; El-Demerdash E
Biochem Pharmacol; 2020 Jul; 177():113942. PubMed ID: 32240652
[TBL] [Abstract][Full Text] [Related]
16. Pyrvinium pamoate ameliorates cyclosporin A- induced hepatotoxicity via the modulation of Wnt/β-catenin signaling and upregulation of PPAR-γ.
Faheem SA; El-Sayed NM; Moustafa YM; Saeed NM; Hazem RM
Int Immunopharmacol; 2022 Mar; 104():108538. PubMed ID: 35074592
[TBL] [Abstract][Full Text] [Related]
17. The impact of pyrvinium pamoate on colon cancer cell viability.
Wiegering A; Uthe FW; Hüttenrauch M; Mühling B; Linnebacher M; Krummenast F; Germer CT; Thalheimer A; Otto C
Int J Colorectal Dis; 2014 Oct; 29(10):1189-98. PubMed ID: 25060218
[TBL] [Abstract][Full Text] [Related]
18. Anti-Tumor Efficacy of Pyrvinium Pamoate Nanoliposomes in an Experimental Model of Melanoma.
Hatamipour M; Jaafari MR; Zangui M; Shakour N; Sahebkar A
Anticancer Agents Med Chem; 2021; 21(17):2379-2384. PubMed ID: 33596812
[TBL] [Abstract][Full Text] [Related]
19. Blocking STAT3 by pyrvinium pamoate causes metabolic lethality in KRAS-mutant lung cancer.
Feng J; Jiang W; Liu Y; Huang W; Hu K; Li K; Chen J; Ma C; Sun Z; Pang X
Biochem Pharmacol; 2020 Jul; 177():113960. PubMed ID: 32298693
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment with artemisinin and oxaliplatin inhibits tumorigenesis in esophageal cancer EC109 cell through Wnt/β-catenin signaling pathway.
Wang T; Wang J; Ren W; Liu ZL; Cheng YF; Zhang XM
Thorac Cancer; 2020 Aug; 11(8):2316-2324. PubMed ID: 32657048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
